Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
- A benign inflammatory skin disorder leading to excessive collagen deposition with thickening and sclerosis of the skin and SC tissues and characteristic plaque formation
- Lesions are well-circumscribed, flat, firm to touch, and have a waxy feel. They may be more easily felt than seen. They are ivory-colored and have a lilac halo border.
- Lesions are not associated with generalized scleroderma/systemic sclerosis based on lack of sclerodactyly, Raynaud phenomenon, and nail fold capillary changes.
- Three phases: active/edematous, inactive/sclerotic/fibrotic, and atrophic lesions
- Morphea is classified into five types (Mayo Classification):
- Plaque: most common subtype especially in adults, well-circumscribed, and confined to dermis
- Generalized: 4+ plaques involving 2+ body sites
- Bullous: rare
- Linear: most common subtype in children
- Deep: more severe and involving all layers from skin to bone, causing limb contractures and muscle atrophy
- Synonym(s): localized scleroderma (LS); scleroderma circumscripta
- Predominant sex: female > male (2.4 to 5:1)
- Peak incidence of plaque subtype in 3rd to 4th decade
- 50% of morphea cases present during childhood.
- Linear morphea can develop before age 10 years in 20% of patients.
- 0.3 to 3 cases per 100,000/year
- Onset in children is between ages 2 and 14 years.
- 50 cases per 100,000 at age 18 years
- 220 cases per 100,000 at age 80 years
Etiology and Pathophysiology
- Sclerosis is limited to the skin and systemic sclerosis is absent.
- Biopsy shows lymphocytic perivascular infiltration of the dermis, decreased number of blood vessels and eccrine (sweat) glands.
- Causation thought to be from vascular damage and enhanced collagen production, although likely with underlying autoimmune etiology
- Drug-induced morphea primarily identified in association with TNF-α inhibitors
- Some association with past trauma, including surgery and vaccination administration, or radiation to the area
Unknown. Raynaud phenomenon is risk factor for systemic scleroderma, not localized.
Commonly Associated Conditions
- Occurs with slightly greater frequency in those with a personal or family history of autoimmune disorders
- Sometimes associated with other diagnosis, such as arthralgias, carpal tunnel syndrome, Raynaud phenomenon, spina bifida, lichen planus, lichen sclerosis, vitiligo, and alopecia areata